is tirzepatide on the fda shortage list OFF Eli Lilly's tirzepatide is off

Obesity continues to be one of the most debated topics among plan sponsors

This medication has been identified as Zepbound 12.5 mg/0.5 mL injection (single-dose pen) and is used for Obstructive Sleep Apnea/Hypopnea Syndrome, and Weight Loss.

A provider-guided tirzepatide microdosing program designed to support metabolic health, cardiovascular risk reduction, and sustainable weight managementenhanced with glycine for optimized performance and recovery.

Discover the difference between the natural GLP-1 hormone and the prescription medication Ozempic to find the best medical weight-loss treatment for your health goals.

Prescription is required.

Administered once weekly by injection, it is suitable for adults with obesity or overweight, especially those with at least one weight-related comorbidity (e.g., type 2 diabetes, hypertension, dyslipidemia, etc.)